Adam Mor

3.5k total citations
65 papers, 2.7k citations indexed

About

Adam Mor is a scholar working on Immunology, Oncology and Immunology and Allergy. According to data from OpenAlex, Adam Mor has authored 65 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 19 papers in Oncology and 16 papers in Immunology and Allergy. Recurrent topics in Adam Mor's work include T-cell and B-cell Immunology (16 papers), Cell Adhesion Molecules Research (14 papers) and Immune Cell Function and Interaction (13 papers). Adam Mor is often cited by papers focused on T-cell and B-cell Immunology (16 papers), Cell Adhesion Molecules Research (14 papers) and Immune Cell Function and Interaction (13 papers). Adam Mor collaborates with scholars based in United States, Israel and India. Adam Mor's co-authors include Mark R. Philips, Michael H. Pillinger, Steven B. Abramson, Michael L. Dustin, G. Keren, Jacob George, David Planer, Galia Luboshits, Marianne Strazza and Ian M. Ahearn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Adam Mor

65 papers receiving 2.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Adam Mor 1.4k 1.0k 517 347 276 65 2.7k
Victoria L. Heath 1.2k 0.9× 901 0.9× 414 0.8× 391 1.1× 225 0.8× 44 3.2k
Claire M. Dubois 1.7k 1.2× 764 0.7× 643 1.2× 379 1.1× 290 1.1× 83 3.8k
Naochika Domae 1.3k 0.9× 744 0.7× 563 1.1× 342 1.0× 160 0.6× 72 2.4k
Anthony Simon 1.8k 1.3× 970 0.9× 371 0.7× 209 0.6× 162 0.6× 111 3.3k
Fredrik Ivars 1.2k 0.9× 2.1k 2.0× 407 0.8× 104 0.3× 243 0.9× 68 3.5k
Susanna C. Fagerholm 962 0.7× 1.0k 1.0× 327 0.6× 349 1.0× 927 3.4× 49 2.6k
Takako Hirata 831 0.6× 1.2k 1.2× 425 0.8× 266 0.8× 646 2.3× 50 2.7k
Björn Rabe 1.1k 0.8× 1.1k 1.1× 962 1.9× 100 0.3× 201 0.7× 32 2.6k
Susanna Scarpa 1.1k 0.8× 451 0.4× 765 1.5× 320 0.9× 162 0.6× 113 2.9k
Anthony W. Ashton 1.8k 1.3× 507 0.5× 498 1.0× 289 0.8× 132 0.5× 87 3.7k

Countries citing papers authored by Adam Mor

Since Specialization
Citations

This map shows the geographic impact of Adam Mor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Mor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Mor more than expected).

Fields of papers citing papers by Adam Mor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Mor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Mor. The network helps show where Adam Mor may publish in the future.

Co-authorship network of co-authors of Adam Mor

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Mor. A scholar is included among the top collaborators of Adam Mor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Mor. Adam Mor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jia, Audun Kvalvaag, Anna S. Tocheva, et al.. (2024). Transmembrane domain–driven PD-1 dimers mediate T cell inhibition. Science Immunology. 9(93). eade6256–eade6256. 17 indexed citations
2.
Bukhari, Shoiab, Kieran Adam, Shalom Lerrer, et al.. (2024). Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity. Journal for ImmunoTherapy of Cancer. 12(3). e008482–e008482. 4 indexed citations
3.
Peled, Michael, Jair Bar, Iris Kamer, et al.. (2021). Mesencephalic astrocyte-derived neurotrophic factor is secreted from interferon-γ–activated tumor cells through ER calcium depletion. PLoS ONE. 16(4). e0250178–e0250178. 5 indexed citations
4.
Strazza, Marianne & Adam Mor. (2020). The Complexity of Targeting Chemokines to Promote a Tumor Immune Response. Inflammation. 43(4). 1201–1208. 21 indexed citations
5.
Sandigursky, Sabina, Mark R. Philips, & Adam Mor. (2020). SAP interacts with CD28 to inhibit PD-1 signaling in T lymphocytes. Clinical Immunology. 217. 108485–108485. 10 indexed citations
6.
García‐España, Antonio, Anna S. Tocheva, Ian M. Ahearn, et al.. (2019). The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals. Journal of Biological Chemistry. 295(14). 4372–4380. 67 indexed citations
7.
Lerrer, Shalom & Adam Mor. (2019). Immune checkpoint inhibitors and the shared epitope theory: from hypothesis to practice. Translational Cancer Research. 8(Suppl 6). S625–S627. 4 indexed citations
8.
Silverman, Gregg J., Doua F. Azzouz, & Adam Mor. (2018). Immune checkpoint inhibitors and the union of bugs against cancer. Kidney International. 93(5). 1030–1032. 2 indexed citations
9.
Shefler, Irit, Pazit Salamon, Francesca Levi‐Schaffer, et al.. (2017). MicroRNA-4443 regulates mast cell activation by T cell–derived microvesicles. Journal of Allergy and Clinical Immunology. 141(6). 2132–2141.e4. 35 indexed citations
10.
Strazza, Marianne, Inbar Azoulay‐Alfaguter, Michael Peled, & Adam Mor. (2016). Assay of Adhesion Under Shear Stress for the Study of T Lymphocyte-Adhesion Molecule Interactions. Journal of Visualized Experiments. 3 indexed citations
11.
Su, Wenjuan, Joseph Wynne, Elaine M. Pinheiro, et al.. (2015). Rap1 and its effector RIAM are required for lymphocyte trafficking. Blood. 126(25). 2695–2703. 59 indexed citations
12.
Azoulay‐Alfaguter, Inbar, Marianne Strazza, & Adam Mor. (2014). Chaperone-mediated specificity in Ras and Rap signaling. Critical Reviews in Biochemistry and Molecular Biology. 50(3). 194–202. 9 indexed citations
13.
Mor, Adam, et al.. (2013). Immunomodulatory Properties of Farnesoids: The New Steroids?. Current Medicinal Chemistry. 20(10). 1218–1224. 9 indexed citations
14.
Mor, Adam, Roni Haklai, Ofer Ben‐Moshe, Yoseph A. Mekori, & Yoel Kloog. (2011). Inhibition of Contact Sensitivity by Farnesylthiosalicylic Acid-Amide, a Potential Rap1 Inhibitor. Journal of Investigative Dermatology. 131(10). 2040–2048. 12 indexed citations
15.
Mor, Adam, Robert L. Wortmann, Hal J. Mitnick, & Michael H. Pillinger. (2011). Drugs Causing Muscle Disease. Rheumatic Disease Clinics of North America. 37(2). 219–231. 15 indexed citations
16.
Shefler, Irit, Pazit Salamon, Tamar Reshef, Adam Mor, & Yoseph A. Mekori. (2010). T Cell-Induced Mast Cell Activation: A Role for Microparticles Released from Activated T Cells. The Journal of Immunology. 185(7). 4206–4212. 79 indexed citations
17.
Mor, Adam, Galia Luboshits, David Planer, G. Keren, & Jacob George. (2006). Altered status of CD4+CD25+ regulatory T cells in patients with acute coronary syndromes. European Heart Journal. 27(21). 2530–2537. 259 indexed citations
18.
Bivona, Trever G., Steven Quatela, Brian O. Bodemann, et al.. (2006). PKC Regulates a Farnesyl-Electrostatic Switch on K-Ras that Promotes its Association with Bcl-Xl on Mitochondria and Induces Apoptosis. Molecular Cell. 21(4). 481–493. 380 indexed citations
19.
Mor, Adam, Steven B. Abramson, & Michael H. Pillinger. (2005). The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clinical Immunology. 115(2). 118–128. 343 indexed citations
20.
Mor, Adam, Yael Shinar, Nurit Zaks, et al.. (2005). Evaluation of Disease Severity in Familial Mediterranean Fever. Seminars in Arthritis and Rheumatism. 35(1). 57–64. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victoria L. Heath Breakdown of academic impact, for papers by Claire M. Dubois Breakdown of academic impact, for papers by Naochika Domae Breakdown of academic impact, for papers by Anthony Simon Breakdown of academic impact, for papers by Fredrik Ivars Breakdown of academic impact, for papers by Susanna C. Fagerholm Breakdown of academic impact, for papers by Takako Hirata Breakdown of academic impact, for papers by Björn Rabe Breakdown of academic impact, for papers by Susanna Scarpa Breakdown of academic impact, for papers by Anthony W. Ashton
Rankless by CCL
2026